Prediction of Recurrence by Preoperative Intratumoral FDG Uptake Heterogeneity in Endometrioid Endometrial Cancer

Prediction of Recurrence by Preoperative Intratumoral FDG Uptake Heterogeneity in Endometrioid Endometrial Cancer

PURPOSE: To investigate the prognostic value of preoperative intratumoral 18F-FDG uptake heterogeneity (IFH) derived from positron emission tomography (PET)/computed tomography (CT) in patients with endometrioid endometrial cancer. METHODS: We retrospectively evaluated clinicopathological data from...

Full description

Bibliographic Details
Main Authors:	Seo Young Kang, Gi Jeong Cheon, Maria Lee, Hee Seung Kim, Jae-Weon Kim, Noh-Hyun Park, Yong Sang Song, Hyun Hoon Chung
Format:	Article
Language:	English
Published:	Elsevier 2017-04-01
Series:	Translational Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523316302273

Similar Items

An integrated prediction model of recurrence in endometrial endometrioid cancers
by: Miller MD, et al.
Published: (2019-06-01)

Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma
by: Ahmed Abu-Zaid, et al.
Published: (2017-09-01)

18F-FDG uptake of visceral adipose tissue on preoperative PET/CT as a predictive marker for breast cancer recurrence
by: Hyun Jeong Kim, et al.
Published: (2022-12-01)

Gastric mucosa as a rare recurrence location of endometrial endometrioid adenocarcinoma
by: Kathleen Lundeberg, et al.
Published: (2024-06-01)

Recurrence Pattern after Adjuvant Radiotherapy for Endometrioid Type Endometrial Cancer
by: Yasin Durmus, et al.
Published: (2018-08-01)

Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence
by: Jesus Gonzalez-Bosquet, et al.
Published: (2022-12-01)

Association Between Maximum Standardize Uptake Value and Prognostic Factors at Endometrioid Type Endometrial Carcinoma
by: Varol Gulseren, et al.
Published: (2020-03-01)

Prognostic factors determining survival after extrapelvic recurrence in endometrioid type endometrial cancer
by: Fatih Kilic, et al.
Published: (2021-11-01)

Combined deep-learning MRI-based radiomic models for preoperative risk classification of endometrial endometrioid adenocarcinoma
by: Jin Yang, et al.
Published: (2023-10-01)

Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy
by: Shin Hye Yoo, et al.
Published: (2021-01-01)

Clinicopathologic significance of mismatch repair protein expression in endometrioid endometrial cancer
by: Mi-Kyung Kim, et al.
Published: (2023-09-01)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
by: Dan Kuai, et al.
Published: (2023-07-01)

Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma
by: Sujin Park, et al.
Published: (2021-08-01)

Prognostic significance of smac/DIABLO in endometrioid endometrial cancer
by: Bozena Dobrzycka, et al.
Published: (2010-04-01)

Prognostic significance of smac/DIABLO in endometrioid endometrial cancer.
by: Magdalena Garbowicz, et al.
Published: (2011-04-01)

Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma
by: Qin Chen, et al.
Published: (2021-01-01)

Oncologic safety of minimally invasive surgery in non-endometrioid endometrial cancer
by: Jung Hwan Ahn, et al.
Published: (2022-06-01)

Abdominopelvic Metastasis of Endometrial Serous Carcinoma Initially Misdiagnosed as Early-Stage Low-Grade Endometrioid Carcinoma: The Importance of Recognizing Minimal Uterine Serous Carcinoma
by: Jiheun Han, et al.
Published: (2020-12-01)

PTEN Immunoexpression in Atypical Endometrial Hyperplasia and Endometrioid Endometrial Carcinoma: A Research Protocol
by: Garima Akhil chandrakar, et al.
Published: (2023-07-01)

Molecular Landscape of the Epithelial–Mesenchymal Transition in Endometrioid Endometrial Cancer
by: Marcin Opławski, et al.
Published: (2021-04-01)

Expression Pattern of Leptin and Its Receptors in Endometrioid Endometrial Cancer
by: Dariusz Boroń, et al.
Published: (2021-06-01)

Biomarkers Associated with Lymph Nodal Metastasis in Endometrioid Endometrial Carcinoma
by: Mathilde Mairé, et al.
Published: (2022-04-01)

Circulating microRNAs as a fingerprint for endometrial endometrioid adenocarcinoma.
by: Lin Wang, et al.
Published: (2014-01-01)

Microsatellite Instability in Young Women with Endometrioid type Endometrial Cancer
by: MR Abbaszadegan, et al.
Published: (2009-09-01)

Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection
by: Ja Kyung Yoon, et al.
Published: (2022-10-01)

Complete Pathologic Response to PARP Inhibitor Olaparib in a Patient with Stage IVB Recurrent Endometrioid Endometrial Adenocarcinoma
by: Rosemary Noel Senguttuvan, et al.
Published: (2023-06-01)

The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma
by: Sainan Gong, et al.
Published: (2023-07-01)

Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus
by: Hanifi Sahin, et al.
Published: (2019-01-01)

Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers
by: Lenka Kalinkova, et al.
Published: (2020-08-01)

The impact of intratumor heterogeneity on anti-tumor immunity
by: Nguyen, Kim Bich
Published: (2023)

Characterization of the endometrial, cervicovaginal and anorectal microbiota in post-menopausal women with endometrioid and serous endometrial cancers.
by: Gregory M Gressel, et al.
Published: (2021-01-01)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
by: Jun Guan, et al.
Published: (2022-10-01)

Characterization of the endometrial, cervicovaginal and anorectal microbiota in post-menopausal women with endometrioid and serous endometrial cancers
by: Gregory M. Gressel, et al.
Published: (2021-01-01)

Preoperative cervical cytology as a prognostic factor in endometrioid-type endometrial cancer: a single-center experience from Saudi Arabia
by: Ahmed Abu-Zaid, et al.
Published: (2020-07-01)

Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma
by: Ashley E. Veade, et al.
Published: (2019-05-01)

Prediction value of 18F-FDG PET/CT intratumor metabolic heterogeneity parameters for recurrence after radical surgery of stage II/III colorectal cancer
by: Xin Liu, et al.
Published: (2022-09-01)

High throughput silencing identifies novel genes in endometrioid endometrial cancer
by: Md Fuzi, Afiqah Alyaa, et al.
Published: (2018)

Thrombocytosis as a Biomarker in Type II, Non-Endometrioid Endometrial Cancer
by: Parker Bussies, et al.
Published: (2020-08-01)

Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth
by: Logan Blankenship, et al.
Published: (2022-11-01)

Risk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary
by: Shuang-zheng Jia, et al.
Published: (2018-04-01)